1Labianca, R, Beretta, GD, Kildani, B, et al. (2010) Colon cancer. Crit Rev Oncol Hematol 74, 106–133.
2Marshall, JR (2008) Prevention of colorectal cancer: diet, chemoprevention, and lifestyle. Gastroenterol Clin North Am 37, 73–82.
3Erickson, KL & Hubbard, NE (2000) Probiotic immunomodulation in health and disease. J Nutr 130, S403–S409.
4Reid, G & Burton, J (2002) Use of Lactobacillus to prevent infection by pathogenic bacteria. Microbes Infect 4, 319–324.
5Chen, CC, Louie, S, Walker, WA, et al. (2005) Preinoculation with the probiotic Lactobacillus acidophilus early in life effectively inhibits murine Citrobacter rodentium colitis. Pediatr Res 58, 1185–1191.
6Bolognani, F, Rumney, CJ, Pool-Zobel, BL, et al. (2001) Effect of lactobacilli, bifidobacteria and inulin on the formation of aberrant crypt foci in rats. Eur J Nutr 40, 293–300.
7Wollowski, I, Ji, ST, Bakalinsky, AT, et al. (1999) Bacteria used for the production of yogurt inactivate carcinogens and prevent DNA damage in the colon of rats. J Nutr 129, 77–82.
8Orrhage, K & Nord, CE (2000) Bifidobacteria and lactobacilli in human health. Drugs Exp Clin Res 26, 95–111.
9Butler, LM, Hewett, PJ, Fitridge, RA, et al. (1999) Deregulation of apoptosis in colorectal carcinoma: theoretical and therapeutic implications. Aust N Z J Surg 69, 88–94.
10Lee, CK, Son, SH, Park, KK, et al. (2008) Isoliquiritigenin inhibits tumor growth and protects the kidney and liver against chemotherapy-induced toxicity in a mouse xenograft model of colon carcinoma. J Pharmacol Sci 106, 444–451.
11Plotnikov, A, Tichler, T, Korenstein, R, et al. (2005) Involvement of the immune response in the cure of metastatic murine CT-26 colon carcinoma by low electric field-enhanced chemotherapy. Int J Cancer 117, 816–824.
12Cho, KH, Lee, HS, Ku, SK, et al. (2008) Decrease in intestinal endocrine cells in Balb/c mice with CT-26 carcinoma cells. J Vet Sci 9, 9–14.
13Scotton, CJ, Wilson, JL, Milliken, D, et al. (2001) Epithelial cancer cell migration: a role for chemokine receptors? Cancer Res 61, 4961–4965.
14Saigusa, S, Toiyama, Y, Tanaka, K, et al. (2010) Stromal CXCR4 and CXCL12 expression is associated with distant recurrence and poor prognosis in rectal cancer after chemoradiotherapy. Ann Surg Oncol 17, 2051–2058.
15Zeelenberg, IS, Ruuls-Van Stalle, L & Roos, E (2003) The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res 63, 3833–3839.
16Mottez, E, Langlade-Demoyen, P, Gournier, H, et al. (1995) Cells expressing a major histocompatibility complex class I molecule with a single covalently bound peptide are highly immunogenic. J Exp Med 181, 493–502.
17Stryhn, A, Pedersen, LO, Holm, A, et al. (2000) Longer peptide can be accommodated in the MHC class I binding site by a protrusion mechanism. Eur J Immunol 30, 3089–3099.
18Schmidt, W, Steinlein, P, Buschle, M, et al. (1996) Transloading of tumor cells with foreign major histocompatibility complex class I peptide ligand: a novel general strategy for the generation of potent cancer vaccines. Proc Natl Acad Sci U S A 93, 9759–9763.
19Alencar, H, King, R, Funovics, M, et al. (2005) A novel mouse model for segmental orthotopic colon cancer. Int J Cancer 117, 335–339.
20Shi, HN, Liu, HY & Nagler-Anderson, C (2000) Enteric infection acts as an adjuvant for the response to a model food antigen. J Immunol 165, 6174–6182.
21Drakes, ML, Blanchard, TG & Czinn, SJ (2005) Colon lamina propria dendritic cells induce a proinflammatory cytokine response in lamina propria T cells in the SCID mouse model of colitis. J Leukoc Biol 78, 1291–1300.
22Mclntosh, GH, Royle, PJ & Playne, MJ (1999) A probiotic strain of L. acidophilus reduces DMH-induced large intestinal tumors in male Sprague–Dawley rats. Nutr Cancer 35, 153–159.
23Kado, S, Uchida, K, Funabashi, H, et al. (2001) Intestinal microflora are necessary for development of spontaneous adenocarcinoma of the large intestine in T-cell receptor beta chain and p53 double-knockout mice. Cancer Res 61, 2395–2398.
24Moore, WE & Moore, LH (1995) Intestinal floras of populations that have a high risk of colon cancer. Appl Environ Microbiol 61, 3202–3207.
25Nakamura, J, Kubota, Y, Miyaoka, M, et al. (2002) Comparison of four microbial enzymes in Clostridia and Bacteroides isolated from human feces. Microbiol lmmunol 46, 487–490.
26Saikali, J, Picard, C, Freitas, M, et al. (2004) Holt, fermented milks, probiotic cultures, and colon cancer. Nutr Cancer 49, 14–24.
27Sekine, K, Ohta, J, Onishi, M, et al. (1995) Analysis of antitumor properties of effector cells stimulated with a cell wall preparation (WPG) of Bifidobacterium infantis. Biol Pharm Bull 18, 148–153.
28O'Mahony, L, Feeney, M, O'Halloran, S, et al. (2001) Probiotic impact on microbial flora, inflammation and tumor development in IL-10 knockout mice. Aliment Pharmacol Ther 15, 1219–1225.
29Saikali, J, Picard, C, Freitas, M, et al. (2004) Fermented milks, probiotic cultures, and colon cancer. Nutr Cancer 49, 14–24.
30Rafter, J (2002) Lactic acid bacteria and cancer: mechanistic perspective. Br J Nutr 88, Suppl. 1, 389–394.
31Orrhage, K, Sillerstrom, E, Gustafsson, JA, et al. (1994) Binding of mutagenic heterocyclic amines by intestinal and lactic acid bacteria. Mutat Res 311, 239–248.
32Saito, Y, Takano, T & Rowland, IR (1992) Effects of soybean oligosaccharides on the human gut microflora in vitro culture. Microb Ecol Health Dis 5, 105–110.
33Linsalata, M, Russo, F, Berloco, P, et al. (2005) Effects of probiotic bacteria (VSL#3) on the polyamine biosynthesis and cell proliferation of normal colonic mucosa of rats. In Vivo 19, 989–995.
34Le Leu, RK, Brown, IL, Hu, Y, et al. (2005) A synbiotic combination of resistant starch and Bifidobacterium lactis facilitates apoptotic deletion of carcinogen-damaged cells in rat colon. J Nutr 135, 996–1001.
35Femia, AP, Luceri, C, Dolara, P, et al. (2002) Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis 23, 1953–1960.
36Ewaschuk, JB, Walker, JW, Diaz, H, et al. (2006) Bioproduction of conjugated linoleic acid by probiotic bacteria occurs in vitro and in vivo in mice. J Nutr 136, 1483–1487.
37Sun, J, Shi, YH, Le, GW, et al. (2005) Distinct immune response induced by peptidoglycan derived from Lactobacillus sp. World J Gastroenterol 11, 6330–6337.
38Linsalata, M & Russo, F (2008) Nutritional factors and polyamine metabolism in colorectal cancer. Nutrition 24, 382–389.
39Salinas, I, Meseguer, J & Esteban, MA (2008) Antiproliferative effects and apoptosis induction by probiotic cytoplasmic extracts in fish cell lines. Vet Microbiol 126, 287–294.
40Lan, A, Lagadic-Gossmann, D, Lemaire, C, et al. (2007) Acidic extracellular pH shifts colorectal cancer cell death from apoptosis to necrosis upon exposure to propionate and acetate, major end-products of the human probiotic propionibacteria. Apoptosis 12, 573–591.
41Los, M, Wesselborg, S & Schulze-Osthoff, K (1999) The role of caspases in development, immunity and apoptotic signal transduction: lessons from knockout mice. Immunity 10, 629–639.
42Yang, J, Liu, X, Bhala, K, et al. (1997) Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275, 1129–1132.
43Prabhudes, SG, Rekhraj, S, Roberts, G, et al. (2007) Apoptosis and chemo-resistance in colorectal cancer. J Surg Oncol 96, 77–88.
44Ottaiano, A, di Palma, A, Napolitano, M, et al. (2005) Inhibitory effects of anti-CXCR4 antibodies on human colon cancer cells. Cancer Immunol Immunother 54, 781–791.
45Müller, A, Homey, B, Soto, H, et al. (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature (Lond) 410, 50–56.
46Guleng, B, Tateishi, K, Ohta, M, et al. (2005) Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner. Cancer Res 65, 5864–5871.
47Lone, YC, Motta, I, Mottez, E, et al. (1998) In vitro induction of specific cytotoxic T lymphocytes using recombinant single-chain MHC class I/peptide complexes. J Immunother 21, 283–294.
48Lybarger, L, Yu, YY, Miley, MJ, et al. (2003) Enhanced immune presentation of a single-chain major histocompatibility complex class I molecule engineered to optimize linkage of a C-terminally extended peptide. J Biol Chem 278, 27105–27111.
49White, J, Crawford, F, Fremont, D, et al. (1999) Soluble class I MHC with β2-microglobulin covalently linked peptides: specific binding to a T cell hybridoma. J Immunol 162, 2671–2676.
50Urbanska, AM, Bhathena, J, Martoni, C, et al. (2009) Estimation of the potential antitumor activity of microencapsulated Lactobacillus acidophilus yogurt formulation in the attenuation of tumorigenesis in Apc(Min/+) Mice. Dig Dis Sci 54, 264–273.